She is now Healthcare Professional Programme Manager at Myeloma UK: “This guideline is an important document for the wide range of healthcare professionals and specialists involved in the care of myeloma patients. The evidence-based recommendations not only provide clarity in aspects of myeloma treatment and management not covered by existing NICE guidance, but also guide best practice in preventing and managing complications and side effects, such as bone disease, pain, fatigue, peripheral neuropathy and infections, all of which can have a huge impact on patients’ quality of life. Importantly the guidelines also recommend the need to provide individualised information and support to patients, families and carers at all stages of the pathway, which is particularly relevant for myeloma patients, whose needs and concerns change throughout the course of their disease.”